The TIDE-Asthma study focused on increasing diversity in clinical trial enrollment by targeting specific racial and ethnic groups. By implementing outreach strategies, including engaging key opinion leaders in diverse communities, the study exceeded its enrollment goals for Hispanic and Asian patients. The study aimed to assess the efficacy, safety, and tolerability of amlitelimab as an add-on therapy for adult patients with moderate to severe asthma. By achieving diversity enrollment goals, the study aimed to accurately reflect treatment outcomes in diverse patient populations and reduce bias. Lessons learned from this study will be applied to future clinical trials across various indications.
Source link
Study identifies strategies for racial, ethnic diversity in clinical trials
